Week of November 29 - December 5, 2015

Osimertinib (Tagrisso™)

Osimertinib (Tagrisso™) is a kinase inhibitor indicated for the treatment of metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer.

Surgical Procedures: Oophorectomy

An oophorectomy is a surgical procedure that is done alone or in combination with another procedure, such as a hysterectomy, to remove the ovaries.

Surgical Procedures: Hysterectomy

A hysterectomy is a surgical procedure that is done to remove the uterus and is often used in cancer treatments.

Cobimetinib (Cotellic™)

Cobimetinib (Cotellic™) is a kinase inhibitor indicated for the treatment of patients with melanoma with a BRAF V600E or V600K mutation.

Trabectedin (Yondelis®)

Trabectedin (Yondelis®) is a chemotherapy used in the treatment of unresectable or metastatic liposarcoma or leiomyosarcoma.

Surgical Treatments: Vulvectomy

A vulvectomy is a procedure in which a surgeon removes all or part of the vulva, most often for the treatment of vulvar cancer.

Irinotecan Liposome (Onivyde™)

New chemotherapy medication indicated in the treatment of metastatic pancreatic cancer.

DSRT: Getting Started

This short video tutorial is based on a presentation given at the Association of Oncology Social Workers (AOSW) Annual Conference. It is a quick introduction to the tool and how to use it in practice.

OncoLink eNews November 2015

Receive cutting-edge information from some of the foremost cancer authorities from the University of Pennsylvania, delivered to your email.